In June 2024 Dermax Brazil and its international commercial collaborators in the foreign market, approved a
budget for the final development of the manufacturing process in introducing a line of unique natural supplements, originally developed and manufactured by Dr. Domingos Loricchio in the United States, comprising 100% natural products, obtained from concentrated purified extracts of various Brazilian plants, aiming to start the manufacture and commercialization of a 100% natural, non-metabolizable and non- glycemic sweetening line of products, with probiotic benefits, safe for consumption by diabetic people, widely tested and approved in the United States.

The project is undergoing commercial feasibility analysis and could result in the beginning of manufacturing and commercial availability of the product on the international market, in the first half of 2025.

In September 2024, Dermax Brazil signed a contract to carry out another Dermasfalt® work on the special paving of 1,696 m2 of river port bare metal areas at the IP4 Waterway Terminal facilities located in the city of Humaitá, in the State of Amazonas, Brazil.

These river port facilities comprise three bridges and one floating steel deck pier, where previously executed paving products did not provide satisfactory and durable results. This work will be carried out completely by Dermax Brasil and directly supervised by the TCU and DNIT, which are government entities directly connected to the contract and can be recommended as a standard for several other paving works in many other IP4 type river ports in the Amazon region, currently lacking of a safe and highly durable paving product.

Dermax has already carried out identical paving works in private river port facilities in the Amazon region, subject to much more intense traffic from heavy vehicles and container trucks, on a much larger scale and with complete success since 2003.